A Dark Vector Cognition product

Item 1. FINANCIAL STATEMENTS

139K characters. Original on sec.gov ·

Item 1. FINANCIAL STATEMENTS

The 48 tables in Item 1. FINANCIAL STATEMENTS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Dow Inc. and Subsidiaries

Consolidated Statements of Income

Three Months EndedNine Months Ended
In millions, except per share amounts (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$10,879$10,730$32,559$34,001
Cost of sales9,8099,59228,88830,096
Research and development expenses208197608616
Selling, general and administrative expenses3963801,2281,216
Amortization of intangibles7681234243
Restructuring and asset related charges - net24—69549
Equity in earnings (losses) of nonconsolidated affiliates2(7)45(112)
Sundry income (expense) - net11992256202
Interest income3644143186
Interest expense and amortization of debt discount199192595549
Income before income taxes3244171,3811,008
Provision for income taxes8490145253
Net income2403271,236755
Net income attributable to noncontrolling interests26256761
Net income available for Dow Inc. common stockholders$214$302$1,169$694
Per common share data:
Earnings per common share - basic$0.30$0.43$1.65$0.97
Earnings per common share - diluted$0.30$0.42$1.65$0.97
Weighted-average common shares outstanding - basic702.3704.0703.5706.4
Weighted-average common shares outstanding - diluted703.6707.5704.9709.7
Depreciation$501$484$1,470$1,443
Capital expenditures$736$597$2,173$1,598

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net income$240$327$1,236$755
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments34(20)8972
Cumulative translation adjustments199(147)34(149)
Pension and other postretirement benefit plans18(2)52—
Derivative instruments31(25)3(45)
Total other comprehensive income (loss)282(194)178(122)
Comprehensive income5221331,414633
Comprehensive income attributable to noncontrolling interests, net of tax26256761
Comprehensive income attributable to Dow Inc.$496$108$1,347$572

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Sep 30, 2024Dec 31, 2023
Assets
Current Assets
Cash and cash equivalents$2,883$2,987
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2024: $111; 2023: $81)5,3804,718
Other1,9361,896
Inventories6,7416,076
Other current assets1,0371,937
Total current assets17,97717,614
Investments
Investment in nonconsolidated affiliates1,3031,267
Other investments (investments carried at fair value - 2024: $2,135; 2023: $1,877)2,8542,740
Noncurrent receivables525438
Total investments4,6824,445
Property
Property62,64260,203
Less: Accumulated depreciation40,54939,137
Net property22,09321,066
Other Assets
Goodwill8,6848,641
Other intangible assets (net of accumulated amortization - 2024: $5,645; 2023: $5,374)1,8402,072
Operating lease right-of-use assets1,3011,320
Deferred income tax assets1,5261,486
Deferred charges and other assets1,2861,323
Total other assets14,63714,842
Total Assets$59,389$57,967
Liabilities and Equity
Current Liabilities
Notes payable$111$62
Long-term debt due within one year296117
Accounts payable:
Trade5,0934,529
Other1,9551,797
Operating lease liabilities - current316329
Income taxes payable257419
Accrued and other current liabilities2,7992,704
Total current liabilities10,8279,957
Long-Term Debt16,16414,907
Other Noncurrent Liabilities
Deferred income tax liabilities397399
Pension and other postretirement benefits - noncurrent4,6894,932
Asbestos-related liabilities - noncurrent727788
Operating lease liabilities - noncurrent1,0231,032
Other noncurrent obligations6,7216,844
Total other noncurrent liabilities13,55713,995
Stockholders’ Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2024: 782,047,707 shares; 2023: 778,595,514 shares)88
Additional paid-in capital9,0558,880
Retained earnings21,45921,774
Accumulated other comprehensive loss(7,503)(7,681)
Treasury stock at cost (2024: 81,956,017 shares; 2023: 76,302,081 shares)(4,708)(4,374)
Dow Inc.’s stockholders’ equity18,31118,607
Noncontrolling interests530501
Total equity18,84119,108
Total Liabilities and Equity$59,389$57,967

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Nine Months Ended
Sep 30, 2024Sep 30, 2023
Operating Activities
Net income$1,236$755
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization2,1431,954
Credit for deferred income tax(134)(817)
Earnings of nonconsolidated affiliates less than dividends received221300
Net periodic pension benefit credit(143)(69)
Pension contributions(92)(111)
Net gain on sales of assets, businesses and investments(58)(49)
Restructuring and asset related charges - net69549
Other net loss332588
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(818)365
Inventories(676)777
Accounts payable601(859)
Other assets and liabilities, net(589)153
Cash provided by operating activities - continuing operations2,0923,536
Cash provided by operating activities - discontinued operations84
Cash provided by operating activities2,1003,540
Investing Activities
Capital expenditures(2,173)(1,598)
Investment in gas field developments(157)(175)
Purchases of previously leased assets—(5)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested3666
Acquisitions of property and businesses, net of cash acquired(121)(103)
Investments in and loans to nonconsolidated affiliates(25)(4)
Distributions and loan repayments from nonconsolidated affiliates—2
Proceeds from sales of ownership interests in nonconsolidated affiliates—63
Purchases of investments(1,381)(1,291)
Proceeds from sales and maturities of investments2,3861,244
Other investing activities, net(21)(45)
Cash used for investing activities(1,456)(1,846)
Financing Activities
Changes in short-term notes payable(61)(122)
Proceeds from issuance of short-term debt greater than three months114—
Payments on short-term debt greater than three months(6)—
Proceeds from issuance of long-term debt1,44376
Payments on long-term debt(224)(355)
Collections on securitization programs288
Purchases of treasury stock(494)(500)
Proceeds from issuance of stock5163
Transaction financing, debt issuance and other costs(13)(1)
Employee taxes paid for share-based payment arrangements(38)(41)
Distributions to noncontrolling interests(49)(51)
Dividends paid to stockholders(1,474)(1,481)
Cash used for financing activities(723)(2,404)
Effect of exchange rate changes on cash, cash equivalents and restricted cash18(130)
Summary
Decrease in cash, cash equivalents and restricted cash(61)(840)
Cash, cash equivalents and restricted cash at beginning of period3,0483,940
Cash, cash equivalents and restricted cash at end of period$2,987$3,100
Less: Restricted cash and cash equivalents, included in "Other current assets"10420
Cash and cash equivalents at end of period$2,883$3,080

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries

Consolidated Statements of Equity

Three Months EndedNine Months Ended
In millions, except per share amounts (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Common Stock
Balance at beginning and end of period$8$8$8$8
Additional Paid-in Capital
Balance at beginning of period9,0128,6618,8808,540
Common stock issued/sold—85163
Stock-based compensation8677285217
Treasury stock issuances - compensation and benefit plans(43)(24)(161)(98)
Balance at end of period9,0558,7229,0558,722
Retained Earnings
Balance at beginning of period21,73922,57021,77423,180
Net income available for Dow Inc. common stockholders2143021,169694
Dividends to stockholders(490)(492)(1,474)(1,481)
Common control transaction——10—
Other(4)(4)(20)(17)
Balance at end of period21,45922,37621,45922,376
Accumulated Other Comprehensive Loss
Balance at beginning of period(7,785)(7,067)(7,681)(7,139)
Other comprehensive income (loss)282(194)178(122)
Balance at end of period(7,503)(7,261)(7,503)(7,261)
Treasury Stock
Balance at beginning of period(4,656)(4,175)(4,374)(3,871)
Treasury stock purchases(95)(127)(495)(505)
Treasury stock issuances - compensation and benefit plans432416198
Balance at end of period(4,708)(4,278)(4,708)(4,278)
Dow Inc.'s stockholders' equity18,31119,56718,31119,567
Noncontrolling Interests530513530513
Total Equity$18,841$20,080$18,841$20,080
Dividends declared per share of common stock$0.70$0.70$2.10$2.10

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$10,879$10,730$32,559$34,001
Cost of sales9,8009,59128,87730,093
Research and development expenses208197608616
Selling, general and administrative expenses3963801,2281,216
Amortization of intangibles7681234243
Restructuring and asset related charges - net24—69549
Equity in earnings (losses) of nonconsolidated affiliates2(7)45(112)
Sundry income (expense) - net11871253169
Interest income3847152194
Interest expense and amortization of debt discount199192595549
Income before income taxes3344001,398986
Provision for income taxes8490145253
Net income2503101,253733
Net income attributable to noncontrolling interests26256761
Net income available for The Dow Chemical Company common stockholder$224$285$1,186$672
Depreciation$501$484$1,470$1,443
Capital expenditures$736$597$2,173$1,598

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Comprehensive Income

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net income$250$310$1,253$733
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments34(20)8972
Cumulative translation adjustments199(147)34(149)
Pension and other postretirement benefit plans18(2)52—
Derivative instruments31(25)3(45)
Total other comprehensive income (loss)282(194)178(122)
Comprehensive income5321161,431611
Comprehensive income attributable to noncontrolling interests, net of tax26256761
Comprehensive income attributable to The Dow Chemical Company$506$91$1,364$550

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Balance Sheets

In millions, except share amounts (Unaudited)Sep 30, 2024Dec 31, 2023
Assets
Current Assets
Cash and cash equivalents$2,883$2,987
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2024: $111; 2023: $81)5,3804,718
Other1,9501,997
Inventories6,7416,076
Other current assets9991,898
Total current assets17,95317,676
Investments
Investment in nonconsolidated affiliates1,3031,267
Other investments (investments carried at fair value - 2024: $2,135; 2023: $1,877)2,8542,740
Noncurrent receivables512424
Total investments4,6694,431
Property
Property62,64260,203
Less accumulated depreciation40,54939,137
Net property22,09321,066
Other Assets
Goodwill8,6848,641
Other intangible assets (net of accumulated amortization - 2024: $5,645; 2023: $5,374)1,8402,072
Operating lease right-of-use assets1,3011,320
Deferred income tax assets1,5261,486
Deferred charges and other assets1,2861,323
Total other assets14,63714,842
Total Assets$59,352$58,015
Liabilities and Equity
Current Liabilities
Notes payable$111$62
Long-term debt due within one year296117
Accounts payable:
Trade5,0934,529
Other1,9921,818
Operating lease liabilities - current316329
Income taxes payable257419
Accrued and other current liabilities2,6732,575
Total current liabilities10,7389,849
Long-Term Debt16,16414,907
Other Noncurrent Liabilities
Deferred income tax liabilities397399
Pension and other postretirement benefits - noncurrent4,6894,932
Asbestos-related liabilities - noncurrent727788
Operating lease liabilities - noncurrent1,0231,032
Other noncurrent obligations6,5756,702
Total other noncurrent liabilities13,41113,853
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each)——
Additional paid-in capital9,4279,091
Retained earnings16,58517,495
Accumulated other comprehensive loss(7,503)(7,681)
The Dow Chemical Company’s stockholder's equity18,50918,905
Noncontrolling interests530501
Total equity19,03919,406
Total Liabilities and Equity$59,352$58,015

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Cash Flows

In millions (Unaudited)Nine Months Ended
Sep 30, 2024Sep 30, 2023
Operating Activities
Net income$1,253$733
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization2,1431,954
Credit for deferred income tax(134)(817)
Earnings of nonconsolidated affiliates less than dividends received221300
Net periodic pension benefit credit(143)(69)
Pension contributions(92)(111)
Net gain on sales of assets, businesses and investments(58)(49)
Restructuring and asset related charges - net69549
Other net loss333589
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable(818)365
Inventories(676)777
Accounts payable601(859)
Other assets and liabilities, net(583)205
Cash provided by operating activities2,1163,567
Investing Activities
Capital expenditures(2,173)(1,598)
Investment in gas field developments(157)(175)
Purchases of previously leased assets—(5)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested3666
Acquisitions of property and businesses, net of cash acquired(121)(103)
Investments in and loans to nonconsolidated affiliates(25)(4)
Distributions and loan repayments from nonconsolidated affiliates—2
Proceeds from sales of ownership interests in nonconsolidated affiliates—63
Purchases of investments(1,381)(1,291)
Proceeds from sales and maturities of investments2,3861,244
Other investing activities, net(21)(45)
Cash used for investing activities(1,456)(1,846)
Financing Activities
Changes in short-term notes payable(61)(122)
Proceeds from issuance of short-term debt greater than three months114—
Payments on short-term debt greater than three months(6)—
Proceeds from issuance of long-term debt1,44376
Payments on long-term debt(224)(355)
Collections on securitization programs288
Proceeds from issuance of stock5163
Transaction financing, debt issuance and other costs(13)(1)
Employee taxes paid for share-based payment arrangements(38)(41)
Distributions to noncontrolling interests(49)(51)
Dividends paid to Dow Inc.(1,984)(2,008)
Cash used for financing activities(739)(2,431)
Effect of exchange rate changes on cash, cash equivalents and restricted cash18(130)
Summary
Decrease in cash, cash equivalents and restricted cash(61)(840)
Cash, cash equivalents and restricted cash at beginning of period3,0483,940
Cash, cash equivalents and restricted cash at end of period$2,987$3,100
Less: Restricted cash and cash equivalents, included in "Other current assets"10420
Cash and cash equivalents at end of period$2,883$3,080

See Notes to the Consolidated Financial Statements.

Table of Contents

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Equity

Three Months EndedNine Months Ended
In millions (Unaudited)Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Common Stock
Balance at beginning and end of period$—$—$—$—
Additional Paid-in Capital
Balance at beginning of period9,3418,8229,0918,627
Issuance of parent company stock - Dow Inc.—85163
Stock-based compensation8677285217
Balance at end of period9,4278,9079,4278,907
Retained Earnings
Balance at beginning of period16,96418,46917,49519,472
Net income available for The Dow Chemical Company common stockholder2242851,186672
Dividends to Dow Inc.(600)(630)(2,077)(2,008)
Other(3)(5)(19)(17)
Balance at end of period16,58518,11916,58518,119
Accumulated Other Comprehensive Loss
Balance at beginning of period(7,785)(7,067)(7,681)(7,139)
Other comprehensive income (loss)282(194)178(122)
Balance at end of period(7,503)(7,261)(7,503)(7,261)
The Dow Chemical Company's stockholder's equity18,50919,76518,50919,765
Noncontrolling Interests530513530513
Total Equity$19,039$20,278$19,039$20,278

See Notes to the Consolidated Financial Statements.

Table of Contents

Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

NotePage
1Consolidated Financial Statements15
2Recent Accounting Guidance16
3Revenue17
4Acquisitions and Divestitures19
5Restructuring and Asset Related Charges - Net19
6Supplementary Information21
7Income Taxes22
8Nonconsolidated Affiliates22
9Earnings Per Share Calculations23
10Inventories23
11Transfers of Financial Assets24
12Notes Payable, Long Term Debt and Available Credit Facilities25
13Commitments and Contingencies27
14Leases29
15Accumulated Other Comprehensive Loss30
16Noncontrolling Interests31
17Pension and Other Postretirement Benefit Plans31
18Stock-Based Compensation32
19Financial Instruments32
20Fair Value Measurements36
21Segments and Geographic Regions38

NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS

Basis of Presentation

Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.

Table of Contents

NOTE 2 – RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

On January 1, 2024, the Company adopted the amendments in Accounting Standards Update ("ASU") 2023-02, "Investments — Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method" and elected to account for certain tax equity investments using the proportional amortization method, as provided by the ASU. Under the proportional amortization method, an entity amortizes the initial cost of tax equity investments in proportion to the income tax credits and other income tax benefits received and recognizes the net amortization and income tax credits and other income tax benefits in the income statement as a component of income tax expense (benefit). The adoption of the ASU did not have a material impact on the Company's consolidated financial statements.

Accounting Guidance Issued But Not Adopted at September 30, 2024

In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, allowing financial statement users to better understand the components of a segment's profit or loss to assess potential future cash flows for each reportable segment and the entity as a whole. The amendments expand a public entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.

SEC Final Rules Not Adopted at September 30, 2024

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. The final rules include requirements to disclose material climate-related risks; activities to mitigate or adapt to such risks; information about the board of directors' oversight of climate-related risks and management’s role in managing material climate-related risks; and information on any climate-related targets or goals that are material to the registrant's business, results of operations, or financial condition. Registrants are also required to disclose the financial statement effects of severe weather events and other natural conditions in the notes to the financial statements. Certain large registrants are also required to disclose Scope 1 and Scope 2 greenhouse gas ("GHG") emissions, when material. The final rules include a phased-in compliance period for all registrants. As a large accelerated filer, most disclosure requirements are effective for the Company beginning with the year ending December 31, 2025. GHG emissions disclosures are required for the year ending December 31, 2026. The Company will also be required to obtain limited assurance on its Scope 1 and Scope 2 GHG emissions disclosures beginning with the year ending December 31, 2029, with reasonable assurance required beginning with the year ending December 31, 2033. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit. The Company is currently evaluating the impact of the final rules on its consolidated financial statements and annual disclosures.

Table of Contents

NOTE 3 – REVENUE

Revenue Recognition

The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 97 percent and 98 percent for the three and nine months ended September 30, 2024, respectively (98 percent for the three and nine months ended September 30, 2023). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At September 30, 2024, the Company had unfulfilled performance obligations of $775 million ($744 million at December 31, 2023) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next five years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 19 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Hydrocarbons & Energy$1,433$1,441$4,347$4,987
Packaging and Specialty Plastics4,0834,01312,11412,521
Packaging & Specialty Plastics$5,516$5,454$16,461$17,508
Industrial Solutions$1,039$1,012$3,107$3,235
Polyurethanes & Construction Chemicals1,9192,0195,8056,343
Other44912
Industrial Intermediates & Infrastructure$2,962$3,035$8,921$9,590
Coatings & Performance Monomers$891$839$2,704$2,572
Consumer Solutions1,3231,2913,9054,031
Performance Materials & Coatings$2,214$2,130$6,609$6,603
Corporate$187$111$568$300
Total$10,879$10,730$32,559$34,001

Table of Contents

Net Trade Sales by Geographic RegionThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
U.S. & Canada$4,149$3,968$12,470$12,667
EMEAI 13,5683,39810,62411,225
Asia Pacific1,8902,0675,7126,172
Latin America1,2721,2973,7533,937
Total$10,879$10,730$32,559$34,001

1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first nine months of 2024 from amounts included in contract liabilities at the beginning of the period was approximately $135 million (approximately $205 million in the first nine months of 2023). In the first nine months of 2024, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (approximately $45 million in the first nine months of 2023).

The following table summarizes contract assets and liabilities at September 30, 2024 and December 31, 2023:

Contract Assets and LiabilitiesBalance Sheet ClassificationSep 30, 2024Dec 31, 2023
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$5,380$4,718
Contract assets - currentOther current assets$1$13
Contract assets - noncurrentDeferred charges and other assets$2$4
Contract liabilities - currentAccrued and other current liabilities$251$195
Contract liabilities - noncurrentOther noncurrent obligations$1,500$1,642

Table of Contents

NOTE 4 – ACQUISITIONS AND DIVESTITURES

Divestiture of the Flexible Packaging Laminating Adhesives Business

On May 2, 2024, the Company announced it entered into a definitive agreement to sell its flexible packaging laminating adhesives business, within Dow's Packaging & Specialty Plastics segment, to Arkema S.A. for approximately $150 million. The divestiture includes five manufacturing sites in the United States, Italy and Mexico as well as the associated inventory, customer contracts and lists, process technology and certain intellectual property. The Company is targeting to close the transaction by the end of 2024, subject to regulatory approval and other closing conditions.

Acquisition of North American Polyethylene Recycler

On August 1, 2024, the Company acquired Circulus Holdings, PBLLC, a U.S. company that recycles plastic waste into post-consumer resin, for a cash purchase of approximately $130 million. The acquisition includes two facilities in the United States with a total recycling capacity of 50,000 metric tons per year and supports Dow's efforts to transform plastic waste and other forms of alternative feedstocks into 3 million metric tons of circular and renewable solutions annually by 2030. The assets acquired and liabilities assumed as part of the acquisition were recorded at their estimated fair value as of the acquisition date, including property of $74 million and intangible assets, consisting primarily of technology and know-how, of $22 million, with the excess of purchase price over the fair value of net assets acquired of $36 million allocated to goodwill. These amounts are subject to adjustment upon completion of the valuation process.

NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET

Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs, see Note 4 to the Consolidated Financial Statements included in the 2023 10-K.

2023 Restructuring Program

On January 25, 2023, the Dow Inc. Board of Directors ("Board") approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the global recessionary environment and to enhance its agility and long-term competitiveness across the economic cycle. These actions are expected to be substantially complete by the end of the first quarter of 2025. In the first quarter of 2024, the Company recorded additional pretax restructuring charges of $8 million for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets within the Industrial Intermediates & Infrastructure segment. In the third quarter of 2024, the Company recorded additional pretax restructuring charges of $7 million for asset write-downs and write-offs related to the shutdown of certain silicones assets within the Performance Materials & Coatings segment. The impacted facilities are expected to be shutdown by the end of 2025. Additionally, the Company recorded a pretax restructuring charge of $16 million for severance and related benefit costs and a pretax restructuring charge of $1 million for additional asset write-downs and write-offs, related to Corporate.

Table of Contents

The following table summarizes the activities related to the 2023 Restructuring Program, including segment information:

2023 Restructuring ProgramSeverance and Related Benefit CostsAsset Write-downs and Write-offsTotal
In millions
Packaging & Specialty Plastics$—$1$1
Industrial Intermediates & Infrastructure—4040
Performance Materials & Coatings—4949
Corporate344107451
Total restructuring charges$344$197$541
Charges against the reserve—(197)(197)
Cash payments(11)—(11)
Reserve balance at Mar 31, 2023$333$—$333
Industrial Intermediates & Infrastructure$—$8$8
Total restructuring charges$—$8$8
Charges against the reserve—(8)(8)
Cash payments(60)—(60)
Reserve balance at Jun 30, 2023$273$—$273
Cash payments(110)—(110)
Reserve balance at Sep 30, 2023$163$—$163
Industrial Intermediates & Infrastructure$—$2$2
Corporate—(16)(16)
Total restructuring charges$—$(14)$(14)
Charges against the reserve—1414
Cash payments(41)—(41)
Reserve balance at Dec 31, 2023$122$—$122
Industrial Intermediates & Infrastructure$—$8$8
Total restructuring charges$—$8$8
Charges against the reserve—(8)(8)
Cash payments(48)—(48)
Reserve balance at Mar 31, 2024$74$—$74
Cash payments$(13)$—$(13)
Reserve balance at Jun 30, 2024$61$—$61
Performance Materials & Coatings$—$7$7
Corporate16117
Total restructuring charges$16$8$24
Charges against the reserve—(8)(8)
Cash payments(17)—(17)
Reserve balance at Sep 30, 2024$60$—$60

At September 30, 2024, $60 million of the reserve balance was included in "Accrued and other current liabilities" ($101 million at December 31, 2023) and zero was included in "Other noncurrent obligations" ($21 million at December 31, 2023) in the consolidated balance sheets.

The Company recorded pretax restructuring charges of $567 million inception-to-date under the 2023 Restructuring Program, consisting of severance and related benefit costs of $360 million and asset write-downs and write-offs of $207 million.

Table of Contents

Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, and costs associated with the Company's productivity and efficiency actions, are expected to result in additional cash expenditures of approximately $90 million, primarily through the first quarter of 2025. Restructuring implementation and efficiency costs totaled $55 million and $157 million for the three and nine months ended September 30, 2024, respectively ($82 million and $169 million for the three and nine months ended September 30, 2023, respectively).

Asset Related Charges

In the first quarter of 2024, the Company recognized pretax impairment charges of $37 million, primarily related to write-downs of certain manufacturing assets in the United States and Italy included in the Company's planned divestiture of its flexible packaging laminating adhesives business. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. See Notes 4 and 20 for additional information.

NOTE 6 – SUPPLEMENTARY INFORMATION

Dow Inc. Sundry Income (Expense) – NetThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Non-operating pension and other postretirement benefit plan net credits 1$61$97$183$290
Foreign exchange losses 2(14)(39)(49)(236)
Gain on sales of other assets and investments 327—4674
Indemnification and other transaction related costs 4121217
Gain on early extinguishment of debt 5——5—
Asset impairments and related costs 6———(18)
Other - net44136975
Total sundry income (expense) – net$119$92$256$202

1.See Note 17 for additional information.

2.Foreign exchange losses for the three months ended September 30, 2024 relate primarily to exposures in the Argentine peso, while losses in the nine months ended September 30, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso. Foreign exchange losses for the three and nine months ended September 30, 2023 relate primarily to exposures in the Argentine peso.

3.The three and nine months ended September 30, 2024 includes a gain of $25 million associated with a warehouse sale. The nine months ended September 30, 2023 includes gains associated with the sale of shares of a previously impaired equity method investment.

4.Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva") as part of the separation and distribution.

5.See Note 12 for additional information.

6.Certain obligations associated with a previously impaired equity method investment.

Sundry income (expense) - net for TDCC for the three and nine months ended September 30, 2024 and 2023 is substantially the same as that of Dow Inc., with the primary difference related to indemnification and other transaction related costs recorded on Dow Inc. Therefore, Sundry income (expense) - net for TDCC is not disclosed separately.

Other Investments

The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

Investments in Company-Owned Life InsuranceSep 30, 2024Dec 31, 2023
In millions
Gross cash value$602$623
Less: Existing drawdowns 126097
Less: Accrued interest on drawdowns 27—
Investments in company-owned life insurance 3$335$526

1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.

2.Included in "Sundry income (expense) - net" in the consolidated statements of income.

3.Classified as "Other investments" in the consolidated balance sheets.

Table of Contents

Supplier Finance Program

The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At September 30, 2024, outstanding obligations confirmed as valid under the SCF program were $304 million ($285 million at December 31, 2023), included in “Accounts payable – Trade” in the consolidated balance sheets.

NOTE 7 – INCOME TAXES

As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision for income taxes, the following income tax discussion does not include reference to TDCC's provision for income taxes or its effective tax rate.

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. In the third quarter of 2024, the Company reported a provision for income taxes of $84 million, resulting in an effective tax rate of 25.9 percent ($90 million in the third quarter of 2023, resulting in an effective tax rate of 21.6 percent). In the first nine months of 2024, the Company reported a provision for income taxes of $145 million, resulting in an effective tax rate of 10.5 percent ($253 million in the first nine months of 2023, resulting in an effective tax rate of 25.1 percent).

The third quarter of 2023 was favorably impacted by a change in reinvestment assertion on a foreign jurisdiction and an increase in tax credits available to the Company. In the first nine months of 2024, the Company recorded a tax credit of $194 million related to a reassessment of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate. The provision for income taxes in the first nine months of 2023 was primarily impacted by the geographic mix of earnings, which resulted in a higher effective tax rate.

NOTE 8 – NONCONSOLIDATED AFFILIATES

For additional information on the Company’s nonconsolidated affiliates, see Note 10 to the Consolidated Financial Statements included in the 2023 10-K.

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets are shown in the following table:

Investments in Nonconsolidated AffiliatesSep 30, 2024Dec 31, 2023
In millions
Investment in nonconsolidated affiliates$1,303$1,267
Other noncurrent obligations(488)(229)
Net investment in nonconsolidated affiliates$815$1,038

At September 30, 2024, the Company had a negative investment balance in Sadara Chemical Company of $420 million included in "Other noncurrent obligations" (negative $128 million at December 31, 2023) in the consolidated balance sheets. The negative investment in Sadara Chemical Company at September 30, 2024 is due to equity losses generated during the first nine months of 2024 driven by the impact of challenging macroeconomic conditions.

At September 30, 2024, the Company had a negative investment balance in EQUATE Petrochemical Company K.S.C.C of $68 million included in "Other noncurrent obligations" (negative $101 million at December 31, 2023) in the consolidated balance sheets. The reduction in the negative investment was driven by improved results in the first nine months of 2024.

Table of Contents

NOTE 9 – EARNINGS PER SHARE CALCULATIONS

The following tables provide earnings per share calculations for Dow Inc. for the three and nine months ended September 30, 2024 and 2023. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income for Earnings Per Share CalculationsThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net income$240$327$1,236$755
Net income attributable to noncontrolling interests26256761
Net income attributable to participating securities 13298
Net income attributable to common stockholders$211$300$1,160$686

1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

Earnings Per Share - Basic and DilutedThree Months EndedNine Months Ended
Dollars per shareSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Earnings per common share - basic$0.30$0.43$1.65$0.97
Earnings per common share - diluted$0.30$0.42$1.65$0.97
Share Count InformationThree Months EndedNine Months Ended
Shares in millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Weighted-average common shares outstanding - basic702.3704.0703.5706.4
Plus dilutive effect of equity compensation plans1.33.51.43.3
Weighted-average common shares outstanding - diluted703.6707.5704.9709.7
Stock units excluded from EPS calculations 110.59.39.69.8

1.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

NOTE 10 – INVENTORIES

The following table provides a breakdown of inventories:

InventoriesSep 30, 2024Dec 31, 2023
In millions
Finished goods$3,853$3,413
Work in process1,4111,234
Raw materials798746
Supplies1,041992
Total$7,103$6,385
Adjustment of inventories to the LIFO basis(362)(309)
Total inventories$6,741$6,076

Table of Contents

NOTE 11 – TRANSFERS OF FINANCIAL ASSETS

Accounts Receivable Programs

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2024 and September 30, 2023. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 13 for additional information related to guarantees.

The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, the "Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2024 and September 30, 2023.

The following table provides a summary of cash flows related to the Programs and the Facilities for the three and nine months ended September 30, 2024 and 2023:

Cash Flows Related to Transfers of Accounts ReceivableThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Proceeds received from new transfers$198$28$1,248$28

The following table provides the balances related to the Programs and the Facilities at September 30, 2024 and December 31, 2023:

Balances Related to Transfers of Accounts ReceivableSep 30, 2024Dec 31, 2023
In millions
Balance outstanding$199$170
Accounts receivable derecognized$153$152
Amounts recognized in the consolidated balance sheets:
Accrued and other current liabilities 1$46$18
  1. Represents amounts collected from customers and not yet remitted by the Company.

Table of Contents

NOTE 12 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Notes PayableSep 30, 2024Dec 31, 2023
In millions
Notes payable to banks and other lenders$111$62
Period-end average interest rates39.13%33.84%
Long-Term Debt2024 Average RateSep 30, 20242023 Average RateDec 31, 2023
In millions
Promissory notes and debentures:
Final maturity 20255.63%$3335.63%$333
Final maturity 20284.80%6004.80%600
Final maturity 20297.58%1,3687.58%1,367
Final maturity 2030 and thereafter 15.11%10,0725.07%8,861
Other facilities:
Foreign currency notes and loans, various rates and maturities2.13%2,7361.18%2,653
InterNotes®, varying maturities through 20544.26%6444.12%595
Finance lease obligations 2961873
Unamortized debt discount and issuance costs(254)(258)
Long-term debt due within one year 3(296)(117)
Long-term debt$16,164$14,907

1.Cost includes net fair value hedge adjustment gains of $70 million at September 30, 2024 ($49 million at December 31, 2023). See Note 19 for additional information.

2.See Note 14 for additional information.

3.Presented net of current portion of unamortized debt issuance costs.

Maturities of Long-Term Debt for Next Five Years at Sep 30, 2024
In millions
2024$35
2025$525
2026$131
2027$1,289
2028$696
2029$1,457

2024 Activity

In the first quarter of 2024, the Company issued $1.25 billion of senior unsecured notes. The offering included $600 million aggregate principal amount of 5.15 percent notes due 2034 and $650 million aggregate principal amount of 5.60 percent notes due 2054. The issuance was completed under the Company's Green Finance Framework. The Company will distribute the proceeds toward projects that support the execution of its sustainability strategy and achieve its targets focused on climate protection and a circular economy, including applicable expenditures and investments related to the Company's Fort Saskatchewan Path2Zero project.

In the second quarter of 2024, the Company redeemed $10 million aggregate principal amount of 2.10 percent notes due November 2030, $30 million aggregate principal amount of 4.25 percent notes due October 2034, $8 million aggregate principal amount of 5.25 percent notes due November 2041 and $12 million aggregate principal amount of 4.375 percent notes due November 2042. As a result of the redemption, the Company recognized a pretax gain on the early extinguishment of debt of $5 million, included in "Sundry income (expense) - net" in the consolidated statements of income.

In the first nine months of 2024, the Company issued an aggregate principal amount of $71 million of InterNotes®. The Company also issued $122 million of foreign currency loans. Additionally, the Company repaid $77 million of long-term debt.

Table of Contents

Available Credit Facilities

The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Sep 30, 2024
In millionsCommitted CreditAvailable CreditMaturity DateInterest
Five Year Competitive Advance and Revolving Credit Facility$5,000$5,000November 2028Floating rate
Bilateral Revolving Credit Facility375375October 2024Floating rate
Bilateral Revolving Credit Facility100100March 2025Floating rate
Bilateral Revolving Credit Facility100100March 2025Floating rate
Bilateral Revolving Credit Facility200200September 2025Floating rate
Bilateral Revolving Credit Facility175175September 2025Floating rate
Bilateral Revolving Credit Facility300300November 2025Floating rate
Bilateral Revolving Credit Facility300300February 2026Floating rate
Bilateral Revolving Credit Facility100100March 2026Floating rate
Bilateral Revolving Credit Facility150150November 2026Floating rate
Bilateral Revolving Credit Facility200200November 2026Floating rate
Bilateral Revolving Credit Facility250250March 2027Floating rate
Bilateral Revolving Credit Facility100100May 2027Floating rate
Bilateral Revolving Credit Facility350350June 2027Floating rate
Bilateral Revolving Credit Facility200200September 2027Floating rate
Bilateral Revolving Credit Facility100100October 2027Floating rate
Bilateral Revolving Credit Facility100100November 2027Floating rate
Bilateral Revolving Credit Facility300300May 2028Floating rate
Total committed and available credit facilities$8,400$8,400

Debt Covenants and Default Provisions

There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first nine months of 2024. For additional information on the Company's debt covenants and default provisions, see Note 13 to the Consolidated Financial Statements included in the 2023 10-K.

Table of Contents

NOTE 13 – COMMITMENTS AND CONTINGENCIES

A summary of the Company's commitments and contingencies can be found in Note 14 to the Consolidated Financial Statements included in the 2023 10-K, which is incorporated by reference herein.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At September 30, 2024, the Company had accrued obligations of $1,157 million for probable environmental remediation and restoration costs ($1,180 million at December 31, 2023), including $240 million for the remediation of Superfund sites ($241 million at December 31, 2023). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

Litigation

Asbestos-Related Matters of Union Carbide Corporation

Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2024 activity, it was determined that no adjustment to the accrual was required at September 30, 2024.

Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $807 million at September 30, 2024 ($867 million at December 31, 2023). At September 30, 2024, approximately 23 percent of the recorded claim liability related to pending claims and approximately 77 percent related to future claims.

Legacy Matters

The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). The costs associated with these Groundwater Matters were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of the Groundwater Matters now deemed to be probable and estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims. As a result, the Company recorded a pretax charge of $177 million, included in "Cost of sales" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure. At September 30, 2024, the total liability related to such alleged Groundwater Matters settlements was $158 million ($232 million at December 31, 2023), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.

The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at September 30, 2024.

Table of Contents

Separately, on October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and included in "Accrued and other current liabilities" in the consolidated balance sheets at September 30, 2024. This is management's best estimate of the loss for which the Company has accrued a liability, although the amount is subject to further arbitration and it is reasonably possible that the total loss could range up to approximately three times that amount.

Indemnifications with Corning Incorporated

The Company had indemnification assets with Corning Incorporated of $58 million at September 30, 2024 ($100 million at December 31, 2023) related to the 2016 ownership restructure of Dow Silicones, which were included in "Other current assets" and "Noncurrent receivables" in the consolidated balance sheets.

Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter

As a result of a 2019 damages judgment related to the ethylene asset matter, Nova Chemicals Corporation was ordered to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars), for which the Company received payment in October 2019 and March 2020. At September 30, 2024, $201 million ($201 million at December 31, 2023) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

Purchase Commitments

In the third quarter of 2024, the Company entered into a commitment for the use of a reservoir asset that will be used to supply water to one of Dow’s main U.S. Gulf Coast manufacturing locations. The related contract is expected to become effective in the fourth quarter of 2024, subject to customary closing conditions, with a 35 year contract period expected to commence in 2028 upon completion of construction. The aggregate value of the fixed and determinable portion over the expected contract period is $1.3 billion (approximately $650 million on a present value basis) at September 30, 2024.

Guarantees

The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

GuaranteesSep 30, 2024Dec 31, 2023
In millionsFinal ExpirationMaximum Future Payments 1Recorded LiabilityFinal ExpirationMaximum Future Payments 1Recorded Liability
Guarantees2038$1,361$1792038$1,385$196

1.In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $232 million at September 30, 2024 ($298 million at December 31, 2023). The Company does not expect to be required to perform under the guarantees.

Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than 1 year to 14 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is $123 million at September 30, 2024 ($150 million at December 31, 2023). The Company expects receivable collections and remittances to occur within the next six months.

Table of Contents

TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.

NOTE 14 – LEASES

For additional information on the Company's leases, see Note 15 to the Consolidated Financial Statements included in the 2023 10-K.

The components of lease cost for operating and finance leases for the three and nine months ended September 30, 2024 and 2023 were as follows:

Lease CostThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Operating lease cost$112$118$329$319
Finance lease cost
Amortization of right-of-use assets - finance31268677
Interest on lease liabilities - finance1183324
Total finance lease cost4234119101
Short-term lease cost8062242194
Variable lease cost280241803683
Sublease income(2)(2)(7)(6)
Total lease cost$512$453$1,486$1,291

The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationNine Months Ended
In millionsSep 30, 2024Sep 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$334$320
Operating cash flows for finance leases$33$24
Financing cash flows for finance leases$95$83
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$186$283
Finance leases$183$43

Table of Contents

NOTE 15 – ACCUMULATED OTHER COMPREHENSIVE LOSS

The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and nine months ended September 30, 2024 and 2023 were as follows:

Accumulated Other Comprehensive LossThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Unrealized Gains (Losses) on Investments
Beginning balance$(198)$(161)$(253)$(253)
Unrealized gains (losses) on investments59(33)13955
Tax (expense) benefit(15)9(35)48
Net unrealized gains (losses) on investments44(24)104103
(Gains) losses reclassified from AOCL to net income 1(12)4(19)(41)
Tax expense (benefit) 22—410
Net (gains) losses reclassified from AOCL to net income(10)4(15)(31)
Other comprehensive income (loss), net of tax34(20)8972
Ending balance$(164)$(181)$(164)$(181)
Cumulative Translation Adjustment
Beginning balance$(2,056)$(1,936)$(1,891)$(1,934)
Gains (losses) on foreign currency translation197(122)42(122)
Tax (expense) benefit8(6)5(16)
Net gains (losses) on foreign currency translation205(128)47(138)
(Gains) losses reclassified from AOCL to net income 3(6)(19)(13)(11)
Other comprehensive income (loss), net of tax199(147)34(149)
Ending balance$(1,857)$(2,083)$(1,857)$(2,083)
Pension and Other Postretirement Benefits
Beginning balance$(5,452)$(4,875)$(5,486)$(4,877)
Gains (losses) arising during the period2(4)2(7)
Amortization of net loss and prior service credits reclassified from AOCL to net income 4213648
Tax expense (benefit) 2(5)(1)(14)(1)
Net loss and prior service credits reclassified from AOCL to net income162507
Other comprehensive income (loss), net of tax18(2)52—
Ending balance$(5,434)$(4,877)$(5,434)$(4,877)
Derivative Instruments
Beginning balance$(79)$(95)$(51)$(75)
Gains (losses) on derivative instruments37(58)(9)(242)
Tax (expense) benefit(9)(2)234
Net gains (losses) on derivative instruments28(60)(7)(208)
(Gains) losses reclassified from AOCL to net income 544513209
Tax expense (benefit) 2(1)(10)(3)(46)
Net (gains) losses reclassified from AOCL to net income33510163
Other comprehensive income (loss), net of tax31(25)3(45)
Ending balance$(48)$(120)$(48)$(120)
Total AOCL ending balance$(7,503)$(7,261)$(7,503)$(7,261)

1.Reclassified to "Net sales" and "Sundry income (expense) - net."

2.Reclassified to "Provision for income taxes."

3.Reclassified to "Sundry income (expense) - net."

4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 17 for additional information.

5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

Table of Contents

NOTE 16 – NONCONTROLLING INTERESTS

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three and nine months ended September 30, 2024 and 2023:

Noncontrolling InterestsThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Balance at beginning of period$482$512$501$529
Net income attributable to noncontrolling interests26256761
Distributions to noncontrolling interests 1(2)(15)(41)(43)
Cumulative translation adjustments24(9)4(34)
Other——(1)—
Balance at end of period$530$513$530$513

1.Includes dividends paid to a joint venture of $8 million for the three and nine months ended September 30, 2024 ($8 million for the three and nine months ended September 30, 2023) which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income.

NOTE 17 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS

A summary of the Company's pension and other postretirement benefit plans can be found in Note 18 to the Consolidated Financial Statements included in the 2023 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

Net Periodic Benefit Cost (Credit) for All Significant PlansThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Defined Benefit Pension Plans
Service cost$14$71$42$212
Interest cost252280754838
Expected return on plan assets(345)(391)(1,034)(1,170)
Amortization of prior service credit(3)(7)(10)(20)
Amortization of net loss342410571
Net periodic benefit credit$(48)$(23)$(143)$(69)
Other Postretirement Benefit Plans
Service cost$1$1$3$3
Interest cost11113334
Amortization of net gain(10)(14)(31)(43)
Net periodic benefit cost (credit)$2$(2)$5$(6)

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

Table of Contents

NOTE 18 – STOCK-BASED COMPENSATION

A summary of the Company's stock-based compensation plans can be found in Note 19 to the Consolidated Financial Statements included in the 2023 10-K.

Stock Incentive Plan

The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2024, Dow Inc. granted the following stock-based compensation awards to employees:

  • 1.3 million stock options with a weighted-average exercise price of $55.17 per share and a weighted-average fair value of $10.94 per share;

  • 2.0 million restricted stock units with a weighted-average fair value of $55.18 per share; and

  • 1.4 million performance stock units with a weighted-average fair value of $58.42 per share.

There was minimal grant activity in the second and third quarters of 2024.

Employee Stock Purchase Plan

The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2024 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at April 1, 2024 (beginning) or October 4, 2024 (ending) of the offering period, whichever is lower.

In the first quarter of 2024, employees subscribed to the right to purchase shares under the 2021 ESPP. In October 2024, 2.4 million shares were delivered to employees under the plan.

NOTE 19 – FINANCIAL INSTRUMENTS

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 20 to the Consolidated Financial Statements included in the 2023 10-K.

Refer to Note 20 for a summary of the fair value of financial instruments at September 30, 2024 and December 31, 2023.

Debt Securities

The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the nine months ended September 30, 2024 and 2023:

Investing ResultsNine Months Ended
In millionsSep 30, 2024Sep 30, 2023
Proceeds from sales of available-for-sale securities$1,730$397
Gross realized gains$34$59
Gross realized losses$(15)$(18)

Table of Contents

The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Sep 30, 2024CostFair Value
In millions
Within one year$90$79
One to five years1,2441,166
Six to ten years422412
After ten years537464
Total$2,293$2,121

Equity Securities

There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three and nine months ended September 30, 2024. There was $1 million of net unrealized losses recognized in earnings on equity securities for the three and nine months ended September 30, 2024 ($4 million of net unrealized losses for the three months ended September 30, 2023 and $6 million of net unrealized gains for the nine months ended September 30, 2023).

Investments in Equity SecuritiesSep 30, 2024Dec 31, 2023
In millions
Readily determinable fair value$14$17
Not readily determinable fair value$173$171

Derivative Instruments

The notional amounts of the Company's derivative instruments at September 30, 2024 and December 31, 2023 were as follows:

Notional Amounts 1Sep 30, 2024Dec 31, 2023
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$1,745$3,000
Foreign currency contracts$6,207$2,316
Derivatives not designated as hedging instruments:
Interest rate contracts$286$59
Foreign currency contracts$14,798$5,824

1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at September 30, 2024 and December 31, 2023 were as follows:

Commodity Notionals 1Sep 30, 2024Dec 31, 2023Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives4.73.7million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.61.4million barrels of oil equivalent

1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2025
Foreign currency contracts2026
Commodity contracts2028

Table of Contents

The following table provides the fair value and balance sheet classification of derivative instruments at September 30, 2024 and December 31, 2023:

Fair Value of Derivative InstrumentsSep 30, 2024Dec 31, 2023
In millionsGrossCounterparty and Cash Collateral Netting 1Net 2GrossCounterparty and Cash Collateral Netting 1Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3$107$(68)$39$73$(73)$—
Interest rate contracts 4———59(56)3
Foreign currency contracts 329(21)821(5)16
Foreign currency contracts 48—85—5
Commodity contracts 338(17)2127(21)6
Commodity contracts 445(39)62(1)1
Total$227$(145)$82$187$(156)$31
Derivatives not designated as hedging instruments:
Interest rate contracts 3$2$(2)$—$4$(3)$1
Foreign currency contracts 320(10)1033(16)17
Commodity contracts 320(11)933(28)5
Commodity contracts 48(3)5———
Total$50$(26)$24$70$(47)$23
Total asset derivatives$277$(171)$106$257$(203)$54
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5$68$(68)$—$95$(73)$22
Interest rate contracts 6———56(56)—
Foreign currency contracts 561(21)408(5)3
Commodity contracts 525(17)834(22)12
Commodity contracts 642(39)32(1)1
Total$196$(145)$51$195$(157)$38
Derivatives not designated as hedging instruments:
Interest rate contracts 5$2$(2)$—$3$(3)$—
Foreign currency contracts 544(10)3438(16)22
Commodity contracts 521(11)1034(28)6
Commodity contracts 66(3)3———
Total$73$(26)$47$75$(47)$28
Total liability derivatives$269$(171)$98$270$(204)$66

1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

2.Represents the net amounts included in the consolidated balance sheets.

3.Included in "Other current assets" in the consolidated balance sheets.

4.Included in "Deferred charges and other assets" in the consolidated balance sheets.

5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.

6.Included in "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $15 million at September 30, 2024 ($22 million at December 31, 2023). There was zero cash collateral posted by counterparties with the Company at September 30, 2024 and December 31, 2023.

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2024 and 2023:

Effect of Derivative InstrumentsGain (loss) recognized in OCI 1Gain (loss) recognized in income 2
Three Months EndedNine Months EndedThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3$—$—$—$—$7$—$(16)$—
Excluded components 3, 451(88)9(93)————
Cash flow hedges:
Interest rate contracts 3——15(2)(3)(11)(7)
Foreign currency contracts 5165(5)61—61
Commodity contracts 5—422(145)(2)(42)(3)(203)
Excluded components 4, 5(2)—(8)—(1)—(5)—
Net foreign investment hedges:
Foreign currency contracts(45)69(37)72————
Excluded components 4, 66416355191226
Total derivatives designated as hedging instruments$26$(6)$(2)$(120)$8$(26)$(17)$(183)
Derivatives not designated as hedging instruments:
Interest rate contracts 3$—$—$—$—$—$—$1$1
Foreign currency contracts 6————(95)(101)(35)(95)
Commodity contracts 5————(2)(1)—3
Total return swap 5————23(16)49(13)
Total derivatives not designated as hedging instruments$—$—$—$—$(74)$(118)$15$(104)
Total derivatives$26$(6)$(2)$(120)$(66)$(144)$(2)$(287)

1.OCI is defined as other comprehensive income (loss).

2.Pretax amounts.

3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.

4.The excluded components are related to the time value of the derivatives designated as hedges.

5.Included in "Cost of sales" in the consolidated statements of income.

6.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsSep 30, 2024
In millions
Cash flow hedges:
Interest rate contracts$(4)
Commodity contracts$11
Foreign currency contracts$(1)
Excluded components$(5)
Net foreign investment hedges:
Excluded components$5

Table of Contents

NOTE 20 – FAIR VALUE MEASUREMENTS

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 21 to the Consolidated Financial Statements included in the 2023 10-K.

Fair Value Measurements on a Recurring Basis

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisSep 30, 2024Dec 31, 2023
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1Level 2$105$—$—$105$485$—$—$485
Money market fundsLevel 21,190——1,190663——663
Marketable securities 2Level 2403—(42)3611,361—(61)1,300
Nonconsolidated affiliates 3Level 3—7
Other investments:
Debt securities: 4
Government debt 5Level 21,10114(92)1,0237663(107)662
Corporate bondsLevel 118——1824—(3)21
Corporate bondsLevel 297410(77)9071,14817(99)1,066
Corporate bondsLevel 3200—(27)173200—(89)111
Equity securities 4, 6Level 1410—14512—17
Derivatives relating to: 7
Interest ratesLevel 2—109—109—136—136
Foreign currencyLevel 2—57—57—59—59
CommoditiesLevel 1—8—8—2—2
CommoditiesLevel 2—103—103—60—60
Total assets at fair value$4,068$4,589
Liabilities at fair value:
Long-term debt including debt due within one year 8Level 2$(16,460)$1,029$(764)$(16,195)$(15,024)$1,089$(747)$(14,682)
Guarantee liability 9Level 3(161)(178)
Derivatives relating to: 7
Interest ratesLevel 2——(70)(70)——(154)(154)
Foreign currencyLevel 2——(105)(105)——(46)(46)
CommoditiesLevel 1——(4)(4)——(2)(2)
CommoditiesLevel 2——(90)(90)——(68)(68)
Total liabilities at fair value$(16,625)$(15,130)

1.The Company's held-to-maturity securities are primarily treasury bills and time deposits. At September 30, 2024, $66 million is included in "Cash and cash equivalents" ($485 million at December 31, 2023) and $39 million is included in "Other current assets" (zero at December 31, 2023) in the consolidated balance sheets.

2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.

3.Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

4.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.

5.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.

6.Equity securities with a readily determinable fair value.

7.See Note 19 for classification of derivatives in the consolidated balance sheets.

8.Cost includes fair value hedge adjustment gains of $70 million at September 30, 2024 and $49 million at December 31, 2023 on $5,129 million of debt at September 30, 2024 and $4,479 million at December 31, 2023.

9.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Table of Contents

Cost approximates fair value for all other financial instruments.

For equity securities calculated at net asset value per share (or its equivalent), the Company had $90 million in private market securities and $16 million in real estate at September 30, 2024 ($86 million in private market securities and $18 million in real estate at December 31, 2023). There are no redemption restrictions and the unfunded commitments on these investments were $84 million at September 30, 2024 and $75 million at December 31, 2023.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security. At December 31, 2023, the level 3 asset values also included an investment in a limited liability company, accounted for as an investment in nonconsolidated affiliates, and with no unfunded commitment.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis

In the first quarter of 2024, the Company recognized impairment charges of $37 million related primarily to write-downs of certain manufacturing assets in the United States and Italy. The assets, classified as Level 3 measurements, were valued at $60 million using unobservable inputs. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics.

In the first quarter of 2024, as part of the 2023 Restructuring Program, the Company recorded impairment charges of $8 million for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

In the third quarter of 2024, as part of the 2023 Restructuring Program, the Company recorded impairment charges of $7 million for asset write-downs and write-offs related to the shutdown of certain silicones assets, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings. Additionally, the Company recorded impairment charges of $1 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Corporate.

Table of Contents

NOTE 21 – SEGMENTS AND GEOGRAPHIC REGIONS

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsCorp.Total
In millions
Three months ended Sep 30, 2024
Net sales$5,516$2,962$2,214$187$10,879
Equity in earnings (losses) of nonconsolidated affiliates$16$(17)$1$2$2
Dow Inc. Operating EBIT 1$618$(53)$140$(64)$641
Three months ended Sep 30, 2023
Net sales$5,454$3,035$2,130$111$10,730
Equity in earnings (losses) of nonconsolidated affiliates$50$(63)$5$1$(7)
Dow Inc. Operating EBIT 1$476$21$179$(50)$626
Nine months ended Sep 30, 2024
Net sales$16,461$8,921$6,609$568$32,559
Equity in earnings (losses) of nonconsolidated affiliates$96$(63)$9$3$45
Dow Inc. Operating EBIT 1$1,926$41$327$(160)$2,134
Nine months ended Sep 30, 2023
Net sales$17,508$9,590$6,603$300$34,001
Equity in earnings (losses) of nonconsolidated affiliates$90$(219)$14$3$(112)
Dow Inc. Operating EBIT 1$2,036$109$280$(206)$2,219

1.Operating EBIT for TDCC for the three and nine months ended September 30, 2024 and 2023 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table.

Reconciliation of "Net income" to Operating EBITThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net income$240$327$1,236$755
+ Provision for income taxes8490145253
Income before income taxes$324$417$1,381$1,008
- Interest income3644143186
+ Interest expense and amortization of debt discount199192595549
- Significant items(154)(61)(301)(848)
Operating EBIT$641$626$2,134$2,219

Table of Contents

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by SegmentThree Months Ended Sep 30, 2024Nine Months Ended Sep 30, 2024
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.TotalPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1$—$—$(7)$(72)$(79)$(37)$(8)$(7)$(174)$(226)
Indemnification and other transaction related costs 2———(75)(75)———(75)(75)
Total$—$—$(7)$(147)$(154)$(37)$(8)$(7)$(249)$(301)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The three and nine months ended September 30, 2024 also include impairment charges related to the write-down of certain manufacturing assets. See Note 5 for additional information.

2.Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 13 for additional information.

Significant Items by SegmentThree Months Ended Sep 30, 2023Nine Months Ended Sep 30, 2023
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.TotalPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1$—$—$—$(82)$(82)$(1)$(48)$(67)$(572)$(688)
Litigation related charges, awards and adjustments 2——————(177)——(177)
Indemnification and other transactions related costs 3———2121———1717
Total$—$—$—$(61)$(61)$(1)$(225)$(67)$(555)$(848)

1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months ended September 30, 2023 also includes certain gains and losses associated with previously impaired equity investments.

2.Includes a loss associated with legacy agricultural products groundwater contamination matters. See Note 13 for additional information.

3.Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

Table of Contents

Previous: Cover and table of contents · Next: Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.